Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy (ACTHiMeN)

This study has been completed.
Sponsor:
Collaborator:
Dutch Kidney Foundation
Information provided by (Responsible Party):
Radboud University
ClinicalTrials.gov Identifier:
NCT00694863
First received: June 9, 2008
Last updated: January 4, 2013
Last verified: December 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)